ADDRESS: Street, City, Country
PHONE: +(123) 456 789
E-MAIL: your-email@mail.com
The funding will support SpliSense’s ongoing global Phase 2b study evaluating SPL84 in people with cystic fibrosis carrying the 3849+10kb C→T mutation.
imphoenix82
Skin Analytics’ DERM Zero brings clinical-grade skin cancer checks to smartphones to improve early detection.
imphoenix82
Health Ministry removes cough syrups from Schedule K, restricts their sale in smaller villages to licensed pharmacies.
imphoenix82
With LivIQ, BIOTRONIK aims to address critical gaps in current leadless pacing technologies.
imphoenix82
According to burn experts, exosome therapy can accelerate healing much more effectively than the current standard of skin grafting, which can leave scarring and a patch-like appearance.
imphoenix82
The targeted radioligand therapy Pluvicto will initially be available through selected hospitals and nuclear medicine centres across India under Novartis’ partnership-led access model.
imphoenix82
Simcere Pharmaceutical and Stanford Medicine join forces to develop innovative therapies for patients with Idiopathic Pulmonary Fibrosis, a chronic, progressive lung disease.
imphoenix82
AI’s greatest contribution may not be replacing human expertise, but enabling that expertise to reach more patients, more quickly, and more effectively.
imphoenix82
The approval enables the introduction of QR678’s patented hair regenerative products in Malaysia and supports its continued expansion across Asia.
imphoenix82
The acquisition strengthens Medtronic’s neurovascular portfolio by adding Scientia’s advanced access technologies, including guidewires and catheters.
imphoenix82HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 8447496924
HealthXploreIndia @2026. All Rights Reserved.
